The duration of adjuvant temozolomide in patients with glioblastoma and the law of diminishing returns

Stuart A. Grossman

doi:10.1093/neuonc/noaa243

The duration of adjuvant temozolomide in patients with glioblastoma and the law of diminishing returns

Stuart A. Grossman

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1721-1722
Number of pages	2
Journal	Neuro-oncology
Volume	22
Issue number	12
DOIs	https://doi.org/10.1093/neuonc/noaa243
State	Published - Dec 1 2020

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

Access to Document

10.1093/neuonc/noaa243

Cite this

@article{fec6d1b6dc5a480f92311a4ae2fdf487,

title = "The duration of adjuvant temozolomide in patients with glioblastoma and the law of diminishing returns",

author = "Grossman, {Stuart A.}",

year = "2020",

month = dec,

day = "1",

doi = "10.1093/neuonc/noaa243",

language = "English (US)",

volume = "22",

pages = "1721--1722",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - The duration of adjuvant temozolomide in patients with glioblastoma and the law of diminishing returns

AU - Grossman, Stuart A.

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85098742361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098742361&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noaa243

DO - 10.1093/neuonc/noaa243

M3 - Editorial

C2 - 33074333

AN - SCOPUS:85098742361

SN - 1522-8517

VL - 22

SP - 1721

EP - 1722

JO - Neuro-oncology

JF - Neuro-oncology

IS - 12

ER -

The duration of adjuvant temozolomide in patients with glioblastoma and the law of diminishing returns

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this